TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ZHEJIANG NOVUS PHARM

Infectious DiseaseDermatology
Pharma

ZHEJIANG NOVUS PHARM is a pharmaceutical company focused on Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.

2023
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

VANCOMYCIN HYDROCHLORIDE 2025-10-02
VANCOMYCIN HYDROCHLORIDE 2025-05-29
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-03-21
VANCOMYCIN HYDROCHLORIDE 2024-07-30
Manufacturing (CMC)
VANCOMYCIN HYDROCHLORIDE 2024-06-26
Efficacy
VANCOMYCIN HYDROCHLORIDE 2024-03-15
Labeling
VANCOMYCIN HYDROCHLORIDE 2024-03-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology